Zelira Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 23 shareholders own 52.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	Malik Majeed	1,134,644	US$470.0k	0%	no data
4.02%	Quincy Street Capital Llc	456,622	US$189.2k	0%	no data
3.78%	Osagie Imasogie	428,883	US$177.7k	0%	no data
3.46%	Sharri Rochlin	393,168	US$162.9k	0%	no data
3.46%	Zoltan Kerekes	393,168	US$162.9k	0%	no data
3.38%	Jason Peterson	383,725	US$159.0k	0%	no data
3.37%	Lisa Gray	381,988	US$158.2k	0%	no data
2.93%	Mera I LLC	332,479	US$137.7k	0%	no data
2.75%	Muller Ct Pty Ltd	312,126	US$129.3k	164%	no data
2.71%	Torsten Geers	307,454	US$127.4k	0%	no data
2.67%	Steve Shapiro	302,571	US$125.3k	0%	no data
2.22%	Mara Gordon	252,242	US$104.5k	0%	no data
1.29%	Chanda Macias	146,479	US$60.7k	0%	no data
1.18%	Mera II LLC	133,372	US$55.2k	0%	no data
1.16%	Oludare Odumosu	131,766	US$54.6k	0%	no data
0.76%	Geers Egag LLC	85,715	US$35.5k	0%	no data
0.67%	Saul Shorr	75,643	US$31.3k	0%	no data
0.67%	Margaret Shorr	75,642	US$31.3k	0%	no data
0.46%	Shannon Hexter	51,695	US$21.4k	0%	no data
0.46%	Daniel Hexter	51,695	US$21.4k	0%	no data
0.34%	Connie Katz	39,032	US$16.2k	0%	no data
0.34%	Samuel Katz	39,032	US$16.2k	0%	no data
0.069%	Timothy Slate	7,881	US$3.3k	0%	no data